Sodium Bicarbonate and N-Acetylcysteine tested for the prevention of serious adverse outcomes

3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Dr Steven Weisbord - Pittsburgh, PA, USA

Educational information

This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.

Faculty

Dr. Steven Weisbord is a nephrologist at the VA Pittsburgh Healthcare System and Associate Professor of Medicine and Clinical and Translational Science at the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.